Innovative Research Award
Samah Algharib — Mississippi State University, United States
Samah Algharib is affiliated with Mississippi State University and works within the broad research area of immunotherapy. The documented research record includes studies addressing antibacterial treatment strategies and veterinary infectious disease, including responsive nanogels, controlled-release hydrogels, and diagnostic perspectives related to bovine mastitis. [1] [2] [3]
Abstract
Samah Algharib, affiliated with Mississippi State University, is associated with research spanning immunotherapy, antibacterial treatment strategies, drug delivery, and veterinary infectious disease. The documented publication record includes investigations of pH- and gelatinase-responsive florfenicol nanogels against Staphylococcus aureus, slow-release florfenicol hydrogels for intestinal bacterial infections, and contemporary approaches to bovine mastitis diagnosis. These studies collectively address therapeutic delivery, antimicrobial effectiveness, controlled release, and disease identification. The supplied research profile records 42 documents, 1,190 citations, and an h-index of 17, providing bibliometric context for the recognition of research activity in pharmaceutical and biomedical applications. [1] [2] [3]
Keywords
Immunotherapy; antibacterial therapy; florfenicol; nanogels; hydrogels; controlled drug release; Staphylococcus aureus; bovine mastitis; veterinary medicine; pharmaceutical research.
Introduction
Research associated with Samah Algharib addresses biomedical and pharmaceutical questions involving antimicrobial treatment and disease management. Published work examines responsive florfenicol nanogels and hydrogels designed to improve therapeutic delivery, while related veterinary research considers contemporary diagnostic approaches for bovine mastitis. These topics connect pharmaceutical formulation with infectious-disease applications. [1] [2] [3]
Research Profile
The supplied profile identifies immunotherapy as the principal subject area, alongside research themes involving antimicrobial agents, drug-delivery systems, bacterial infections, and veterinary health. The publications demonstrate attention to formulation characteristics, release behavior, antibacterial activity, and diagnostic considerations, providing a multidisciplinary context for pharmaceutical and biomedical investigation. [1] [2] [3]
Research Contributions
The documented studies contribute to research on responsive and controlled antimicrobial delivery. One study investigates pH- and gelatinase-responsive florfenicol nanogels against Staphylococcus aureus, while another examines slow-release florfenicol hydrogels for intestinal bacterial infections. Related work reviews concepts and advances in bovine mastitis diagnosis, connecting treatment research with disease detection. [1] [2] [3]
Publications
The supplied publication set includes research on enhanced antibacterial effects of pH/gelatinase-responsive florfenicol nanogels, manipulated slow release of florfenicol hydrogels, and basic concepts and recent advances in bovine mastitis diagnosis. These publications collectively reflect research interests spanning pharmaceutical formulation, antimicrobial intervention, controlled release, veterinary disease management, and diagnostic science. [1] [2] [3]
Research Impact
The supplied bibliometric profile records 42 documents, 1,190 citations, and an h-index of 17. These indicators provide quantitative context for the reach of the indexed research record, while the cited publications demonstrate applications in antimicrobial treatment, drug delivery, and veterinary diagnostics. Bibliometric measures should be interpreted alongside publication quality and research context. [1] [2] [3]
Award Suitability
For an Innovative Research Award, the documented work provides evidence of research involving responsive nanogels, controlled-release hydrogels, antibacterial treatment, and veterinary diagnostic perspectives. The combination of formulation-oriented pharmaceutical research and infectious-disease applications demonstrates identifiable innovation themes that can be considered alongside the supplied publication record, citation indicators, affiliation, and the specific criteria established by the awarding organization. [1] [2] [3]
Conclusion
Samah Algharib’s documented research profile encompasses immunotherapy-related interests, antimicrobial delivery, florfenicol formulations, bacterial infection treatment, and bovine mastitis diagnostics. The supplied record combines publication activity with reported citation indicators and research addressing practical biomedical and veterinary challenges. These materials provide a structured basis for academic recognition under the stated Innovative Research Award category. [1] [2] [3]
External Links
References
- Enhanced antibacterial effect of pH/gelatinase-responsive florfenicol nanogels against Staphylococcus aureus. (2025). PubMed.
https://pubmed.ncbi.nlm.nih.gov/40292404/
- Manipulated slow release of florfenicol hydrogels for effective treatment of anti-intestinal bacterial infections. (n.d.). International Journal of Nanomedicine, Dove Medical Press.
https://www.dovepress.com/manipulated-slow-release-of-florfenicol-hydrogels-for-effective-treatm-peer-reviewed-fulltext-article-IJN
- Basic concepts, recent advances, and future perspectives in the diagnosis of bovine mastitis. (2023). Journal of Veterinary Science. https://doi.org/10.4142/jvs.23147
https://vetsci.org/DOIx.php?id=10.4142/jvs.23147